WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.

Quotes for WntResearch AB

Right Now

+/-
0.016
%
3,78%
Latest
0.439
High
0.444
Low
0.413
Volume
176 029
Turnover (SEK)
76 424
Market Value (MSEK)
58,5
Time (Latest trade)

Board

CEO

  • Pernilla Sandwall

Chairperson of the Board

  • Christer Nordstedt

Board

  • Bengt Gustavsson
  • Gudrun Anstrén
  • Janna Sand-Dejmek
  • Peter Ström
  • Tommy Andersson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 11,08 11,08 2022-09-28
Linfan Zhang 5,14 5,14 2022-09-28
Nordnet Pensionsförsäkring 4,86 4,86 2022-09-28
Thomas Mellqvist 1,96 1,96 2022-09-28
Gunvald Berger 1,55 1,55 2022-09-28
Kjell Stenberg 1,51 1,51 2022-09-28
Niclas Evertsson 1,46 1,46 2022-09-28
Lars-Erik Forsgårdh 1,31 1,31 2022-09-28
Christos Tziolas 0,96 0,96 2022-09-28
Tommy Andersson 0,82 0,82 2022-09-28
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-12-12 Extra bolagsstämma 2022

  • 2023-02-09 Bokslutskommuniké 2022

  • 2023-05-04 Delårsrapport 2023-Q1

  • 2023-06-01 Årsstämma 2022

  • 2023-08-17 Delårsrapport 2023-Q2

  • 2023-11-16 Delårsrapport 2023-Q3